Ieso delivers AI-powered, therapist-delivered digital cognitive behavioural therapy and is developing autonomous digital assessment and treatment products (digital therapeutics). Its core assets include the world’s largest outcomes-linked therapy dataset—over 460,000 therapy hours and more than 500 million data points—and a network of about 600 qualified therapists. Ieso currently serves more than 20 million adults via NHS partnerships and uses its data and AI tools to review sessions and drive improved recovery outcomes. The company plans to seek regulatory approval for autonomous digital tools in the US and UK, expand its commercial teams in the US, and pursue co-development and distribution partnerships for scalable market access. The funds raised will be used to advance AI-enabled, evidence-based digital therapeutics through regulatory approvals and to bring products to market in the US and UK. Ieso Digital Health provides digitally-enhanced mental health care services to health providers, private individuals, and businesses via a secure, written conversation platform. The company’s system uses proven, evidence-based approaches to treatment to ensure superior adherence to clinical models. Ieso invests in continuous professional development for its therapists to ensure quality control and promote retention. Led by CEO Dan Clark, the company focuses on delivering therapy through its digitally mediated platform. Ieso closed a $24M funding round to accelerate commercialization and product development activities. The company plans to use the funds to expand its commercialization and product development in the U.S. and the U.K.

Total raised

$76M

Funding rounds

2

Latest round

Series B

Latest activity

Nov 2021